Skip to main content

and
  1. Article

    Open Access

    Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts

    Determining the somatic mutations of epidermal growth factor receptor (EGFR)-pathway networks is the key to effective treatment for non-small cell lung cancer (NSCLC) with tyrosine kinase inhibitors (TKIs).The...

    S Li, L Li, Y Zhu, C Huang, Y Qin, H Liu, L Ren-Heidenreich in British Journal of Cancer (2014)